CN115746134A - 半乳糖凝集素-3的免疫测定 - Google Patents

半乳糖凝集素-3的免疫测定 Download PDF

Info

Publication number
CN115746134A
CN115746134A CN202111203392.8A CN202111203392A CN115746134A CN 115746134 A CN115746134 A CN 115746134A CN 202111203392 A CN202111203392 A CN 202111203392A CN 115746134 A CN115746134 A CN 115746134A
Authority
CN
China
Prior art keywords
antibody
seq
antigen
galectin
binding portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111203392.8A
Other languages
English (en)
Chinese (zh)
Inventor
林潮喜
张君
何丹
温志刚
周帅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Ruimeng Innovation Biotechnology Co ltd
Original Assignee
Shenzhen Ruimeng Innovation Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Ruimeng Innovation Biotechnology Co ltd filed Critical Shenzhen Ruimeng Innovation Biotechnology Co ltd
Priority to CN202111203392.8A priority Critical patent/CN115746134A/zh
Priority to PCT/CN2022/124770 priority patent/WO2023061388A1/fr
Publication of CN115746134A publication Critical patent/CN115746134A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
CN202111203392.8A 2021-10-15 2021-10-15 半乳糖凝集素-3的免疫测定 Pending CN115746134A (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202111203392.8A CN115746134A (zh) 2021-10-15 2021-10-15 半乳糖凝集素-3的免疫测定
PCT/CN2022/124770 WO2023061388A1 (fr) 2021-10-15 2022-10-12 Dosage immunologique de galectine-3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111203392.8A CN115746134A (zh) 2021-10-15 2021-10-15 半乳糖凝集素-3的免疫测定

Publications (1)

Publication Number Publication Date
CN115746134A true CN115746134A (zh) 2023-03-07

Family

ID=85332777

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111203392.8A Pending CN115746134A (zh) 2021-10-15 2021-10-15 半乳糖凝集素-3的免疫测定

Country Status (2)

Country Link
CN (1) CN115746134A (fr)
WO (1) WO2023061388A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102226809A (zh) * 2011-02-13 2011-10-26 倪润洲 检测Galectin-3的时间分辨免疫荧光试剂盒
CN103513038A (zh) * 2013-05-16 2014-01-15 武汉生之源生物科技有限公司 半乳糖凝集素3检测试剂盒及制备方法
CN103869079A (zh) * 2014-03-06 2014-06-18 瑞莱生物工程（深圳）有限公司 一种快速定量检测半乳糖凝集素-3的胶体金试纸
EP2910645A1 (fr) * 2014-02-25 2015-08-26 STRATIFYER Molecular Pathology GmbH Procédés et compositions pour la prédiction de l'efficacité thérapeutique de traitements du cancer et le pronostic du cancer lors d'un traitement à base d'anticorps
CN107383192A (zh) * 2017-07-19 2017-11-24 深圳市倍诺博生物科技有限公司 半乳糖凝集素‑3检测试剂盒
CN111505304A (zh) * 2019-01-31 2020-08-07 艾维可生物科技有限公司 一种化学发光法检测半乳糖凝集素-3的试剂盒及使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106771258A (zh) * 2017-02-16 2017-05-31 广州赛太特生物医学科技有限公司 一种半乳糖凝集素‑3结合蛋白的检测试剂盒及其方法和应用
EP3466975A1 (fr) * 2017-10-05 2019-04-10 Laboratoire Français du Fractionnement et des Biotechnologies Molécule de liaison spécifique dirigée contre la protéine galectin-3
JP7539834B2 (ja) * 2018-02-01 2024-08-26 メモリアル スローン ケタリング キャンサー センター ガレクチン－３に対する抗体及びその使用方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102226809A (zh) * 2011-02-13 2011-10-26 倪润洲 检测Galectin-3的时间分辨免疫荧光试剂盒
CN103513038A (zh) * 2013-05-16 2014-01-15 武汉生之源生物科技有限公司 半乳糖凝集素3检测试剂盒及制备方法
EP2910645A1 (fr) * 2014-02-25 2015-08-26 STRATIFYER Molecular Pathology GmbH Procédés et compositions pour la prédiction de l'efficacité thérapeutique de traitements du cancer et le pronostic du cancer lors d'un traitement à base d'anticorps
CN103869079A (zh) * 2014-03-06 2014-06-18 瑞莱生物工程（深圳）有限公司 一种快速定量检测半乳糖凝集素-3的胶体金试纸
CN107383192A (zh) * 2017-07-19 2017-11-24 深圳市倍诺博生物科技有限公司 半乳糖凝集素‑3检测试剂盒
CN111505304A (zh) * 2019-01-31 2020-08-07 艾维可生物科技有限公司 一种化学发光法检测半乳糖凝集素-3的试剂盒及使用方法

Also Published As

Publication number Publication date
WO2023061388A1 (fr) 2023-04-20

Similar Documents

Publication Publication Date Title
KR101593641B1 (ko) 중동호흡기증후군 코로나바이러스 뉴클레오캡시드를 인식하는 항체 및 그의 용도
CN107383192B (zh) 半乳糖凝集素-3检测试剂盒
WO2013132347A2 (fr) Immunodosage elisa amélioré de la calprotectine
JP2008513536A (ja) プロガストリンに対するモノクローナル抗体
US9347954B2 (en) Antibody capable of binding to specific region of periostin, and method of measuring periostin using the same
JP2014533827A (ja) アドレノメジュリンアッセイおよび成熟アドレノメジュリンの測定方法
TW200813428A (en) Antibody pair screening methods
WO2008054724A2 (fr) Anticorps monoclonaux contre l'ostéopontine
JP5002001B2 (ja) インスリンレセプターαサブユニットの測定方法
US20040248216A1 (en) Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor
JP5137015B2 (ja) Ｐｔｘ３高感度測定法
RU2607588C2 (ru) Способ получения агента, связывающегося с препро-вазопрессином или с его фрагментами
EA034364B1 (ru) Иммуноанализ для обнаружения хромогранина а
KR101338517B1 (ko) 인간 간-카르복실에스터라제 １을 특이적으로 인식하는 단일클론 항체, 상기 항체를 생산하는 하이브리도마 세포주 및 이의 용도
CN116023489A (zh) 与NT-proBNP特异性结合的抗体以及其用途
CN111303289B (zh) 抗人Tn型糖基化MUC1抗体及其用途
WO2023061388A1 (fr) Dosage immunologique de galectine-3
JP2014115186A (ja) 胃癌、肺癌及び／又は食道癌の検出方法
EP3779438A1 (fr) Méthode de détection d'insuffisance cardiaque, instrument de détection d'insuffisance cardiaque, méthode d'immunoessai en sandwich et combinaison d'anticorps
US20140294850A1 (en) Early childhood membranous nephropathy due to cationic bovine serum albumin
JP6407990B2 (ja) アウグリン免疫学的検定
JP2012018119A (ja) 大腸癌検出用マーカーおよびそれを用いた大腸癌検出方法
WO2023068248A1 (fr) Procédé de dosage immunologique pour n-télopeptide réticulé de collagène de type i, kit de dosage immunologique, et anticorps ou fragment d'anticorps de celui-ci
EP4317172A1 (fr) Procédé d'analyse immunologique pour un télopeptide c-terminal de collagène de type i
WO2021193763A1 (fr) Procédé de mesure pour fragment comprenant le domaine 7s du collagène de type iv humain, et kit à utiliser pour celui-ci

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40089501

Country of ref document: HK